Filing Flows

Filing Flows › Companies › Nexgel › Cash flow

Nexgel cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$2.2M in Q2 2026 · −$3.2M over twelve months

Operating cash flow−$2.2M
Free cash flow−$2.2M

Analysis

In Q2 2026, Nexgel generated −$2.2M of operating cash flow. That is $1.8M less than in Q2 2025 (−$407K).

Over the twelve months to Jun 30, 2026, operating cash flow was −$3.2M; the largest uses were other investing ($6.6M), operating cash flow ($3.2M), net borrowing (+) / repaid (−) ($164K); besides operations, cash came from other financing ($11.0M); the cash balance rose by $981K.

Operating cash flow was −$2.2M against net income of −$3.6M. The largest differences: depreciation & amortization +$827K, prepaid and other assets −$491K, receivables −$416K.

Free cash flow

Nexgel: free cash flow by quarterNexgel: free cash flow by quarter−$1.2MQ3 2024−$859KQ4 2024−$400KQ1 2025−$407KQ2 2025−$793KQ3 2025$281KQ4 2025−$513KQ1 2026−$2.2MQ2 2026
Operating cash flow less capital spending.
Nexgel: operating cash flow against capital spendingNexgel: operating cash flow against capital spendingOperating cash flowCapital spending−$1.2M$13KQ3 2024−$859K$0Q4 2024−$400K$0Q1 2025−$407K$0Q2 2025−$785K$8KQ3 2025$281K$0Q4 2025−$504K$9KQ1 2026−$2.2M$0Q2 2026
Latest (Q2 2026): Operating cash flow −$2.2M, Capital spending $0.

Capital allocation, year by year

Nexgel: where the cash came from (up) and went (down), by fiscal yearNexgel: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedCapital spendingAcquisitionsFY2021: Operating cash flow −$2.8MFY2021: Net borrowing $2.9MFY2021: Shares issued $13.5MFY2021: Capital spending −$269K$16.3MFY2021FY2022: Operating cash flow −$3.0MFY2022: Net borrowing −$3.7MFY2022: Capital spending −$96KFY2022FY2023: Operating cash flow −$3.2MFY2023: Net borrowing $210KFY2023: Capital spending −$696KFY2023: Acquisitions −$500K$210KFY2023FY2024: Operating cash flow −$3.9MFY2024: Net borrowing $218KFY2024: Shares issued $3.8MFY2024: Capital spending −$443K$4.0MFY2024FY2025: Operating cash flow −$1.3MFY2025: Net borrowing −$156KFY2025: Shares issued $963KFY2025: Capital spending −$68K$963KFY2025
Over these 5 years operating cash flow totalled −$14.2M; the largest uses were operating cash flow ($14.2M) and net borrowing ($3.8M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$492K
Debt$563K
Net debt$71K
Due within a year$99K
Cash runway2 months

Nexgel is burning cash: its operations consume cash, a free cash flow of −$3.2M a year at the current rate against $492K of cash and investments: a runway of about 2 months; $99K of debt also comes due within a year, which would need refinancing or new money before any new financing.

Nexgel: debt maturities by year (FY2025)Nexgel: debt maturities by year (FY2025)$99KYear 1$106KYear 2$114KYear 3$24KYear 4$6KYear 5$239KAfter year 5
Principal due in each year as disclosed in the annual report, against $492K of cash and investments now.

Where the cash came from and went

Nexgel: sources (+) and uses (−) of cash, Q2 2026Nexgel: sources (+) and uses (−) of cash, Q2 2026Net borrowing (+) / repaid (−)$8.5MOther investing−$6.6MOperating cash flow−$2.2MCash drawn (+) / kept (−)$416KOther financing−$182K
Nexgel: sources (+) and uses (−) of cash, TTM to Q2 2026Nexgel: sources (+) and uses (−) of cash, TTM to Q2 2026Other financing$11.0MOther investing−$6.6MOperating cash flow−$3.2MCash drawn (+) / kept (−)−$981KNet borrowing (+) / repaid (−)−$164K

From profit to cash

Nexgel: net income to operating cash flow, Q2 2026Nexgel: net income to operating cash flow, Q2 2026Net income−$3.6MDepreciation & amortization$827KStock-based pay$119KReceivables−$416KInventory−$14KPayables$345KAccrued liabilities$284KPrepaid and other assets−$491KOperating cash flow−$2.2M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.

Every quarter

QuarterOperating cash flowCapital spendingNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026−$2.2M—$8.5M—$416K−$2.2M
Q1 2026−$504K−$9K$1.6M—−$1.1M−$513K
Q4 2025$281K—−$42K−$92K$800K$281K
Q3 2025−$785K−$8K−$37K—−$1.1M−$793K
Q2 2025−$407K—−$40K—$467K−$407K
Q1 2025−$400K—−$37K—$615K−$400K
Q4 2024−$859K—−$38K$1.6M−$748K−$859K
Q3 2024−$1.2M−$13K−$40K$1.2M$10K−$1.2M

Nexgel: income statement and cash flow

Nexgel, Q2 2026: revenue $3.7M (+28% year over year), operating margin -68.0%. The chart follows the revenue to costs, profit and cash.

Nexgel: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.